Aummune
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6 Weizmann, Tel Aviv, Tel Aviv, IsraelWebsite
www.aummune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Aummune
Aummune is a clinical-stage biopharmaceutical company that develops a first-of-its-kind individualized drug-customization platform aimed at treating solid tumors. Their proprietary platform utilizes an efficacy-driven selection process to create patient-specific tri-functional aptamer drugs that induce cancer cell death and activate immune responses. The company targets patients with locally advanced or metastatic solid tumors, offering a new class of individualized immunotherapy. Aummune's lead product, AM003, is currently undergoing a Phase 1 trial to evaluate its safety and tolerability.Explore more
Aummune Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aummune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Aummune had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Aummune has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Aummune recently announced quarterly report
Aummune, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Aummune is spiking on competitors!
Product Launch: Get notified when Aummune launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Aummune
Funding: Get notified immidiatlly once Aummune has new funding data
Recommended Actions
Find VP level buyers at Aummune
Find 3 more new buyers
Company Profile Activity
Activity Insights
Aummune is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aummune is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aummune.
Aummune Tech Stack
A closer look at the technologies used by Aummune
See more technologies
Aummune News & Media
Aummune’s Poster at ASCO 2024 to Highlight Ongoing Phase 1 Trial for AM003
TEL AVIV, Israel, May 28, 2024 (GLOBE NEWSWIRE) -- Aummune, a clinical-stage biopharmaceutical company developing a unique class of oligonucleotide drugs to treat solid tumors, announced today that an abstract of the Company’s Phase 1 trial of its proprietary, investigational product AM003 will be presented on June 1, 2024, at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO2024) taking place in Chicago, Illinois.
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Aummune
Sign Up For FreeTo access detailed company insights
Aummune is a clinical-stage biopharmaceutical company that develops a first-of-its-kind individualized drug-customization platform aimed at treating solid tumors. Their proprietary platform utilizes an efficacy-driven selection process to create patient-specific tri-functional aptamer drugs that induce cancer cell death and activate immune response... Read More
